[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

2019 Future of Brain Ischemia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Brain Ischemia Report Description- The 2019 pipeline study on Brain Ischemia pipeline is a comprehensive research on the ... wise count of Brain Ischemia pipeline Company wise list of Brain Ischemia pipeline Mechanism of Action wise Brain Ischemia pipeline For each pipeline ...

February 2019 42 pages

2019 Future of Canavan Disease R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Canavan Disease Report Description- The 2019 pipeline study on Canavan Disease pipeline is a comprehensive research on the ... and actionable insights. Scope of Canavan Disease pipeline report includes- An overview of Canavan Disease disease including symptoms, causes, diagnosis ...

February 2019 25 pages

2019 Future of Cancer related Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Cancer related Pain Report Description- The 2019 pipeline study on Cancer related Pain pipeline is a comprehensive research on ... wise count of Cancer related Pain pipeline Company wise list of Cancer related Pain pipeline Mechanism of Action wise Cancer related Pain pipeline ...

February 2019 110 pages

2019 Future of Cerebral Palsy (CP) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Cerebral Palsy (CP) Report Description- The 2019 pipeline study on Cerebral Palsy (CP) pipeline is a comprehensive research on the drug candidates ...

February 2019 40 pages

2019 Future of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Report Description- The 2019 pipeline study on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline is a comprehensive ...

February 2019 45 pages

2019 Future of Chronic Traumatic Encephalopathy (CTE) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Chronic Traumatic Encephalopathy (CTE) Report Description- The 2019 pipeline study on Chronic Traumatic Encephalopathy (CTE) pipeline is a comprehensive research ...

February 2019 40 pages

2019 Future of Cluster Headache Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Cluster Headache Syndrome Report Description- The 2019 pipeline study on Cluster Headache Syndrome pipeline is a comprehensive research on the drug ...

February 2019 40 pages

2019 Future of Cognitive Impairment Associated With Schizophrenia (CIAS) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Cognitive Impairment Associated With Schizophrenia (CIAS) Report Description- The 2019 pipeline study on Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline ...

February 2019 80 pages

2019 Future of Complex Regional Pain Syndrome (CPRS) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Complex Regional Pain Syndrome (CPRS) Report Description- The 2019 pipeline study on Complex Regional Pain Syndrome (CPRS) pipeline is a comprehensive ...

February 2019 40 pages

2019 Future of Dental Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Dental Pain Report Description- The 2019 pipeline study on Dental Pain pipeline is a comprehensive research on the drug ... Phase wise count of Dental Pain pipeline Company wise list of Dental Pain pipeline Mechanism of Action wise Dental Pain pipeline For each pipeline ...

February 2019 35 pages

2019 Future of Devic’s Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Devic’s Syndrome Report Description- The 2019 pipeline study on Devic’s Syndrome pipeline is a comprehensive research on the ... wise count of Devic’s Syndrome pipeline Company wise list of Devic’s Syndrome pipeline Mechanism of Action wise Devic’s Syndrome pipeline For each ...

February 2019 80 pages

2019 Future of Drug Addiction R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... Drug Addiction pipeline companies from advancing their products into Phase 3 or Phase 4. Drug Addiction Report Description- The 2019 pipeline study on Drug Addiction pipeline is a comprehensive research on the drug ...

February 2019 150 pages

2019 Future of Dyskinesia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Dyskinesia Report Description- The 2019 pipeline study on Dyskinesia pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Dyskinesia product pipeline are provided. Company overview, snapshot and ...

February 2019 130 pages

2019 Future of Encephalitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Encephalitis Report Description- The 2019 pipeline study on Encephalitis pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Encephalitis product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Encephalomyelitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Encephalomyelitis Report Description- The 2019 pipeline study on Encephalomyelitis pipeline is a comprehensive research on the ... and actionable insights. Scope of Encephalomyelitis pipeline report includes- An overview of Encephalomyelitis disease including symptoms, causes, ...

February 2019 45 pages

2019 Future of Encephalopathy R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Encephalopathy Report Description- The 2019 pipeline study on Encephalopathy pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Encephalopathy product pipeline are provided. Company overview, snapshot and ...

February 2019 60 pages

2019 Future of Fatigue R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Fatigue Report Description- The 2019 pipeline study on Fatigue pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Fatigue product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Fibromyalgia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Fibromyalgia Report Description- The 2019 pipeline study on Fibromyalgia pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Fibromyalgia product pipeline are provided. Company overview, snapshot and ...

February 2019 60 pages

2019 Future of Friedreich Ataxia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Friedreich Ataxia Report Description- The 2019 pipeline study on Friedreich Ataxia pipeline is a comprehensive research on the drug candidates ...

February 2019 70 pages

2019 Future of Globoid Cell Leukodystrophy R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Globoid Cell Leukodystrophy Report Description- The 2019 pipeline study on Globoid Cell Leukodystrophy pipeline is a comprehensive research on the drug ...

February 2019 40 pages

2019 Future of Guillain-Barre Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... some of the Guillain-Barre Syndrome pipeline companies from advancing their products into Phase 3 or Phase 4. Guillain-Barre Syndrome Report Description- The 2019 pipeline study on Guillain-Barre Syndrome pipeline is a comprehensive ...

February 2019 40 pages

2019 Future of Hepatic Encephalopathy (HE) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Hepatic Encephalopathy (HE) Report Description- The 2019 pipeline study on Hepatic Encephalopathy (HE) pipeline is a comprehensive research on the drug candidates ...

February 2019 45 pages

2019 Future of Hyperalgesia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Hyperalgesia Report Description- The 2019 pipeline study on Hyperalgesia pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Hyperalgesia product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Insomnia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Insomnia Report Description- The 2019 pipeline study on Insomnia pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Insomnia product pipeline are provided. Company overview, snapshot and ...

February 2019 90 pages

2019 Future of Interstitial Cystitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Interstitial Cystitis Report Description- The 2019 pipeline study on Interstitial Cystitis pipeline is a comprehensive research on the drug candidates ...

February 2019 50 pages

2019 Future of Krabbe Disease R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... products into Phase 3 or Phase 4. Krabbe Disease Report Description- The 2019 pipeline study on Krabbe Disease pipeline is a comprehensive research on the ... and actionable insights. Scope of Krabbe Disease pipeline report includes- An overview of Krabbe Disease disease including symptoms, causes, diagnosis and ...

February 2019 40 pages

2019 Future of Low Back Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Low Back Pain Report Description- The 2019 pipeline study on Low Back Pain pipeline is a comprehensive research on the ... Phase wise count of Low Back Pain pipeline Company wise list of Low Back Pain pipeline Mechanism of Action wise Low Back Pain pipeline For each ...

February 2019 100 pages

2019 Future of Metachromatic Leukodystrophy (MLD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Metachromatic Leukodystrophy (MLD) Report Description- The 2019 pipeline study on Metachromatic Leukodystrophy (MLD) pipeline is a comprehensive research on the drug ...

February 2019 40 pages

2019 Future of Mild Cognitive Impairment (MCI) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Mild Cognitive Impairment (MCI) Report Description- The 2019 pipeline study on Mild Cognitive Impairment (MCI) pipeline is a comprehensive research ...

February 2019 65 pages

2019 Future of Multiple System Atrophy (MSA) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Multiple System Atrophy (MSA) Report Description- The 2019 pipeline study on Multiple System Atrophy (MSA) pipeline is a comprehensive research ...

February 2019 50 pages

2019 Future of Narcolepsy R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Narcolepsy Report Description- The 2019 pipeline study on Narcolepsy pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Narcolepsy product pipeline are provided. Company overview, snapshot and ...

February 2019 70 pages

2019 Future of Neuromyelitis Optica (Devic’s Syndrome) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Neuromyelitis Optica (Devic’s Syndrome) Report Description- The 2019 pipeline study on Neuromyelitis Optica (Devic’s Syndrome) pipeline is a comprehensive research ...

February 2019 80 pages

2019 Future of Nicotine Addiction R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Nicotine Addiction Report Description- The 2019 pipeline study on Nicotine Addiction pipeline is a comprehensive research on the drug candidates ...

February 2019 60 pages

2019 Future of Obsessive Compulsive Disorder (OCD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Obsessive Compulsive Disorder (OCD) Report Description- The 2019 pipeline study on Obsessive Compulsive Disorder (OCD) pipeline is a comprehensive research ...

February 2019 40 pages

2019 Future of Opioid/Opium Addiction R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... some of the Opioid/Opium Addiction pipeline companies from advancing their products into Phase 3 or Phase 4. Opioid/Opium Addiction Report Description- The 2019 pipeline study on Opioid/Opium Addiction pipeline is a comprehensive ...

February 2019 90 pages

2019 Future of Periodontitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Periodontitis Report Description- The 2019 pipeline study on Periodontitis pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Periodontitis product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Post-Traumatic Stress Disorder (PTSD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... Post-Traumatic Stress Disorder (PTSD) pipeline companies from advancing their products into Phase 3 or Phase 4. Post-Traumatic Stress Disorder (PTSD) Report Description- The 2019 pipeline study on Post-Traumatic Stress ...

February 2019 110 pages

2019 Future of Progressive Supranuclear Palsy (PSP) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Progressive Supranuclear Palsy (PSP) Report Description- The 2019 pipeline study on Progressive Supranuclear Palsy (PSP) pipeline is a comprehensive research ...

February 2019 65 pages

2019 Future of Reflex sympathetic dystrophy syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Reflex sympathetic dystrophy syndrome Report Description- The 2019 pipeline study on Reflex sympathetic dystrophy syndrome pipeline is a comprehensive research on the ...

February 2019 40 pages

2019 Future of Restless Legs Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Restless Legs Syndrome Report Description- The 2019 pipeline study on Restless Legs Syndrome pipeline is a comprehensive research on the drug ...

February 2019 45 pages

2019 Future of Rett Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Rett Syndrome Report Description- The 2019 pipeline study on Rett Syndrome pipeline is a comprehensive research on the ... wise count of Rett Syndrome pipeline Company wise list of Rett Syndrome pipeline Mechanism of Action wise Rett Syndrome pipeline For each pipeline ...

February 2019 80 pages

2019 Future of Sedation R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Sedation Report Description- The 2019 pipeline study on Sedation pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Sedation product pipeline are provided. Company overview, snapshot and ...

February 2019 55 pages

2019 Future of Shy-Drager Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... some of the Shy-Drager Syndrome pipeline companies from advancing their products into Phase 3 or Phase 4. Shy-Drager Syndrome Report Description- The 2019 pipeline study on Shy-Drager Syndrome pipeline is a comprehensive ...

February 2019 50 pages

2019 Future of Smoking Addiction R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Smoking Addiction Report Description- The 2019 pipeline study on Smoking Addiction pipeline is a comprehensive research on the drug candidates ...

February 2019 80 pages

2019 Future of Spinal Muscular Atrophy (SMA) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Spinal Muscular Atrophy (SMA) Report Description- The 2019 pipeline study on Spinal Muscular Atrophy (SMA) pipeline is a comprehensive research ...

February 2019 95 pages

2019 Future of Tourette Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Tourette Syndrome Report Description- The 2019 pipeline study on Tourette Syndrome pipeline is a comprehensive research on the drug candidates ...

February 2019 45 pages

2019 Future of Trigeminal Neuralgia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... from advancing their products into Phase 3 or Phase 4. Trigeminal Neuralgia Report Description- The 2019 pipeline study on Trigeminal Neuralgia pipeline is a comprehensive research on the drug candidates ...

February 2019 45 pages

2019 Future of Visceral Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Visceral Pain Report Description- The 2019 pipeline study on Visceral Pain pipeline is a comprehensive research on the ... wise count of Visceral Pain pipeline Company wise list of Visceral Pain pipeline Mechanism of Action wise Visceral Pain pipeline For each pipeline ...

February 2019 85 pages

2019 Future of Xerostomia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... their products into Phase 3 or Phase 4. Xerostomia Report Description- The 2019 pipeline study on Xerostomia pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Xerostomia product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Acromegaly R&D Pipeline Drugs and Companies- Analysis of Global Acromegaly Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 1,979.00

... advancing their products into Phase 3 or Phase 4. Acromegaly Report Description The H1 2019 pipeline review report on Acromegaly pipeline is a comprehensive study on the candidates in development ...

January 2019 65 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers